MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hypoxia in cancers results in the upregulation of hypoxia inducible factor 1 (HIF-1) and a microRNA, hsa-miR-210 (miR-210) which is associated with a poor prognosis. METHODS AND FINDINGS: In human cancer cell lines and tumours, we found that miR-210 targets the mitochondrial iron sulfur scaffold protein ISCU, required for assembly of iron-sulfur clusters, cofactors for key enzymes involved in the Krebs cycle, electron transport, and iron metabolism. Down regulation of ISCU was the major cause of induction of reactive oxygen species (ROS) in hypoxia. ISCU suppression reduced mitochondrial complex 1 activity and aconitase activity, caused a shift to glycolysis in normoxia and enhanced cell survival. Cancers with low ISCU had a worse prognosis. CONCLUSIONS: Induction of these major hallmarks of cancer show that a single microRNA, miR-210, mediates a new mechanism of adaptation to hypoxia, by regulating mitochondrial function via iron-sulfur cluster metabolism and free radical generation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, in other studies, miR210-mediated suppression of ETC and TCA enzymes were found to correlate with enhanced anaerobic glycolysis and increases in lactate production (81, 129).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [129]
In the citing paper
“Subsequent studies by other investigators confirm the role of miR210 in suppressing ISCU1/2 and as well as other factors (cytochrome c oxidase assembly protein) essential for ETC assembly (81, 129).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601 · cited 2×
“induced by the BH3 domain protein BNIP3, [8], and cytochrome C oxidase subunits may switch to more efficient ones [9].”
BackgroundRetractedMicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · cited 1×
“Recently microRNAs (miRs), which are small (,22 nt) noncoding RNAs that regulate post-transcriptional gene expression by blocking translation of target mRNAs or by accelerating their degradation [10,11], have been reported to be induced by hypoxia.”
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · cited 10×
“In particular, complex III is a major contributor to ROS in hypoxia [32] and complex I and II contribute about 30% of the ROS [33].”
BackgroundInfluential(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“Hypoxia is a major physiological difference between tumours and normal tissue, mainly generated by tumour growth with inadequate blood supply and consumption of oxygen by tumour cells [reviewed in [1]].”
BackgroundSelf-citationGene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., Banham, A. H., Pezzella, F., Boultwood, J., Wainscoat, J. S., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07077.x · Cited by 1,735 · cited 1×
“We have previously shown miR-210 can be detected at an elevated level in serum of cancer patients [38] so it will be of interest if they reflect the metabolic state of their primary cancer and hence could be used in future therapy selection.”
BackgroundSelf-citationMitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545 · cited 13×
“Found at: doi:10.1371/journal.pone.0010345.s005 (0.97 MB TIF) Figure S5 Hypoxia regulates ISCU via HIF1a induction of miR-210. miR-210 represses ISCU 39-UTR and reduces ISCU protein.”
BackgroundInfluential
Cited by
Di Leva, G., Garofalo, M., & Croce, C. M. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104715 · Cited by 1,672
Oxidative stress and cancer: An overview
Sosa, V., Moliné, T., Somoza, R., Paciucci, R., Kondoh, H., & LLeonart, M. E. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.10.004 · Cited by 1,439
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Semenza, G. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67230 · Cited by 1,335
“Among the targets of miR-210 that are downregulated in hypoxic cells are mRNAs encoded by the ISCU gene, which encodes an iron-sulfur cluster assembly enzyme that is required for the activity of mitochondrial electron transport complex I (41, 42).”
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Schito, L., & Semenza, G. L. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.016 · Cited by 962
Advances in Hypoxia-Inducible Factor Biology
Choudhry, H., & Harris, A. L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.005 · Cited by 868
Self-citationMitochondrial composition and function under the control of hypoxia
Fuhrmann, D. C., & Brüne, B. (2017) · Redox Biology · doi:10.1016/j.redox.2017.02.012 · Cited by 643
Hypoxia-Inducible Factor 1 and Cardiovascular Disease
Semenza, G. L. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170322 · Cited by 608
Hypoxia-inducible factors: cancer progression and clinical translation
Wicks, E. E., & Semenza, G. L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci159839 · Cited by 580
“HIF-1–mediated expression of the microRNA miR-210 inhibits the expression of the iron-sulfur cluster scaffold proteins ISCU1 and ISCU2, which are required for complex I assembly, thereby decreasing mitochondrial respiration (60, 61).”
BackgroundRedox regulation of mitochondrial function
Handy, D. E., & Loscalzo, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4123 · Cited by 588
“Similarly, in other studies, miR210-mediated suppression of ETC and TCA enzymes were found to correlate with enhanced anaerobic glycolysis and increases in lactate production (81, 129).”
ResultHypoxia-Modified Cancer Cell Metabolism
Al Tameemi, W., Dale, T. P., Al-Jumaily, R. M. K., & Forsyth, N. R. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00004 · Cited by 503
Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target
Infantino, V., Santarsiero, A., Convertini, P., Todisco, S., & Iacobazzi, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115703 · Cited by 499
“Decrease of ISCU induces ROS formation under hypoxia [110].”
BackgroundVascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
Ramakrishnan, S., Anand, V., & Roy, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9531-7 · Cited by 442
Mitochondria and Iron: current questions
Paul, B. T., Manz, D. H., Torti, F. M., & Torti, S. V. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2016.1268047 · Cited by 423
Hypoxia. 2. Hypoxia regulates cellular metabolism
Wheaton, W. W., & Chandel, N. S. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00485.2010 · Cited by 426
Puisségur, M.-P., Mazure, N. M., Bertero, T., Pradelli, L., Grosso, S., Robbe-Sermesant, K., Maurin, T., Lebrigand, K., Cardinaud, B., Hofman, V, et al. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.119 · Cited by 423
Garofano, L., Migliozzi, S., Oh, Y. T., D’Angelo, F., Najac, R. D., Ko, A., Frangaj, B., Caruso, F. P., Yu, K., Yuan, J., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00159-4 · Cited by 364
Tello, D., Balsa, E., Acosta-Iborra, B., Fuertes-Yebra, E., Elorza, A., Ordóñez, Á., Corral-Escariz, M., Soro, I., López-Bernardo, E., Perales-Clemente, E., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.008 · Cited by 368
Semenza, G. L. (2017) · The EMBO Journal · doi:10.15252/embj.201695204 · Cited by 366
“…metabolism, including inhibition of fatty acid oxidation, which also generates acetyl-CoA (Huang et al, 2014), induction of mitochondrial-selective autophagy (Zhang et al, 2008; Bellot et al, 2009), and inhibition of ETC complex I activity (Chan et al, 2009; Favaro et al, 2010; Tello et al, 2011).”
BackgroundCHAN, Y. C., BANERJEE, J., CHOI, S. Y., & SEN, C. K. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2011.00154.x · Cited by 364
“ISCU1 ⁄ 2 expression is negatively correlated with miR-210 level in wide variety of cells, such as human pulmonary endothelial cells [11], breast cancer cells [27], colon cancer cells [27], and trophoblasts [55].”
BackgroundRegulation of Metabolism by Hypoxia-Inducible Factor 1
Semenza, G. L. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010678 · Cited by 342
“HIF-1 also activates transcription of a microRNA, miR-210, which inhibits the expression of a protein required for formation of ironsulfur clusters that are components of the TCA cycle enzyme aconitase and electron transport chain Complex I (Chan et al. 2009; Chen et al. 2010; Favaro et al. 2010).”
BackgroundNew aspects of the Warburg effect in cancer cell biology
Bensinger, S. J., & Christofk, H. R. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.02.003 · Cited by 307
Buffa, F. M., Camps, C., Winchester, L., Snell, C. E., Gee, H. E., Sheldon, H., Taylor, M., Harris, A. L., & Ragoussis, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0489 · Cited by 308
Self-citationThe Redox Basis of Epigenetic Modifications: From Mechanisms to Functional Consequences
Cyr, A. R., & Domann, F. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3492 · Cited by 297
Masson, N., & Ratcliffe, P. J. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-3 · Cited by 298
“For instance, transcriptional activation of the micro-RNA miR-210 by HIF leads to a down-regulation of multiple targets important for mitochondrial function, including NDUFA4, SDHD, the iron-sulfur cluster assembly proteins ISCU1/2 and the COX assembly protein COX10 [130,131].”
BackgroundMicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1α Activity during Prolonged Hypoxia
Bruning, U., Cerone, L., Neufeld, Z., Fitzpatrick, S. F., Cheong, A., Scholz, C. C., Simpson, D. A., Leonard, M. O., Tambuwala, M. M., Cummins, E. P., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01276-10 · Cited by 289
miR‐210: More than a silent player in hypoxia
Devlin, C., Greco, S., Martelli, F., & Ivan, M. (2011) · IUBMB Life · doi:10.1002/iub.427 · Cited by 289
“This mechanism may be dependent on the suppression of ISCU, SDHD, NDUFA4, and the resulting generation of ROS and TCA metabolites, such as succinate.”
BackgroundInfluentialSelf-citationThe EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
Ivan, M., & Kaelin, W. G. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.002 · Cited by 273
“As a result, antioxidants such as ascorbate are usually included when measuring EGLN activity in vitro (Flashman et al., 2010; Knowles et al., 2003).”
Self-citationHypoxia: A master regulator of microRNA biogenesis and activity
Nallamshetty, S., Chan, S. Y., & Loscalzo, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.022 · Cited by 281
Marie-Egyptienne, D. T., Lohse, I., & Hill, R. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.11.019 · Cited by 256
Wang, H., Flach, H., Onizawa, M., Wei, L., McManus, M. T., & Weiss, A. (2014) · Nature Immunology · doi:10.1038/ni.2846 · Cited by 251
The Warburg effect: Insights from the past decade
Upadhyay, M., Samal, J., Kandpal, M., Singh, O. V., & Vivekanandan, P. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.003 · Cited by 243
MIR-210 modulates mitochondrial respiration in placenta with preeclampsia
Muralimanoharan, S., Maloyan, A., Mele, J., Guo, C., Myatt, L. G., & Myatt, L. (2012) · Placenta · doi:10.1016/j.placenta.2012.07.002 · Cited by 237
“In addition a mechanistic link between miR-210, HIF-1α, mitochondria associated proteins, and mitochondrial function has been identified in cancer cells (24, 25).”
BackgroundCheng, X., Ku, C.-H., & Siow, R. C. M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.025 · Cited by 218
Kelly, T. J., Souza, A. L., Clish, C. B., & Puigserver, P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01242-10 · Cited by 218
“2696 fur cluster stability and aconitase activity due to downregulation of the protein ISCU1/2 (11, 12, 19).”
BackgroundMiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines
Grosso, S., Doyen, J., Parks, S. K., Bertero, T., Paye, A., Cardinaud, B., Gounon, P., Lacas-Gervais, S., Noël, A., Pouysségur, J., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.71 · Cited by 216
(2017) · Anticancer Research · doi:10.21873/anticanres.12107 · Cited by 210
MitomiRs in human inflamm-aging: A hypothesis involving miR-181a, miR-34a and miR-146a
Rippo, M. R., Olivieri, F., Monsurrò, V., Prattichizzo, F., Albertini, M. C., & Procopio, A. D. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.03.002 · Cited by 209
“…expression of the mitochondrial iron sulfur cluster homolog ISCU, thus affecting aconitase and mitochondrial complex activity) (Chan et al., 2009) (Favaro et al., 2010); and let-7b, which seems to have several potential mitochondrial targets, i.e. ATP6 (ATP synthase F0 subunit 6), ATP8 (ATP…”
BackgroundOxygen availability and metabolic reprogramming in cancer
Xie, H., & Simon, M. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.799973 · Cited by 206
“Moreover, an miR-210 antagonist decreases clonogenic survival in hypoxic MCF7 and HeLa cells (52).”
BackgroundYuan, G., Khan, S. A., Luo, W., Nanduri, J., Semenza, G. L., & Prabhakar, N. R. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22640 · Cited by 201
“…(physiological) response to continuous hypoxia, in which HIF-1 mediates the expression of multiple pathways that modulate or decrease mitochondrial respiration and ROS generation (Kim et al., 2006; Fukuda et al., 2007; Zhang et al., 2008a; Chan et al., 2009; Chen et al., 2010; Favaro et al., 2010).”
BackgroundOxidative Stress and MicroRNAs in Vascular Diseases
Magenta, A., Greco, S., Gaetano, C., & Martelli, F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917319 · Cited by 196
Bao, B., Azmi, A. S., Ali, S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., & Sarkar, F. H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.008 · Cited by 180
“It has been documented that hypoxia induces the increased expression of miR-210 in all the cells tested including cancer cells [351,374,376-383].”
BackgroundMcCormick, R. I., Blick, C., Ragoussis, J., Schoedel, J., Mole, D. R., Young, A. C., Selby, P. J., Banks, R. E., & Harris, A. L. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.56 · Cited by 175
“It has been previously published by our group and others that ISCU is a miR-210 target (Chan et al, 2009; Chen et al, 2010; Favaro et al, 2010).”
BackgroundSelf-citationMutharasan, R. K., Nagpal, V., Ichikawa, Y., & Ardehali, H. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01080.2010 · Cited by 174
Hypoxia and hypoxia inducible factors in tumor metabolism
Zeng, W., Liu, P., Pan, W., Singh, S. R., & Wei, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.01.032 · Cited by 170
Multiple functions of hypoxia-regulated miR-210 in cancer
Qin, Q., Furong, W., & Baosheng, L. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-50 · Cited by 165
“regulation [18,22,26-30], cell survival [31-36], differentiation [37-40], angiogenesis [41-51] as well as metabolism [52-57].”
BackgroundInfluentialHypoxia-regulated microRNAs in human cancer
Shen, G., Li, X., Jia, Y.-F., Piazza, G. A., & Xi, Y. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.195 · Cited by 164
The VHL-dependent regulation of microRNAs in renal cancer
Neal, C. S., Michael, M. Z., Rawlings, L. H., Van der Hoek, M. B., & Gleadle, J. M. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-64 · Cited by 164
“We have defined a large number of potential miR-210 targets using such methodology, and during the course of this study Chan and colleagues [57] and subsequently others [58-60] were able to experimentally validate the regulation of one such predicted target, ISCU1/2.”
MitomiRs delineating the intracellular localization of microRNAs at mitochondria
Bandiera, S., Matégot, R., Girard, M., Demongeot, J., & Henrion-Caude, A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.013 · Cited by 158
Acclimatization of skeletal muscle mitochondria to high‐altitude hypoxia during an ascent of Everest
Levett, D. Z., Radford, E. J., Menassa, D. A., Graber, E. F., Morash, A. J., Hoppeler, H., Clarke, K., Martin, D. S., Ferguson‐Smith, A. C., Montgomery, H. E., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-197772 · Cited by 153
Kim, J. H., Park, S. G., Song, S.-Y., Kim, J. K., & Sung, J.-H. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.117 · Cited by 152
Oxidative Stress Under Ambient and Physiological Oxygen Tension in Tissue Culture
Jagannathan, L., Cuddapah, S., & Costa, M. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0050-5 · Cited by 150
Control of mitochondrial activity by miRNAs
Li, P., Jiao, J., Gao, G., & Prabhakar, B. S. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24004 · Cited by 141
“, 2007; Corn, 2008], is reported to be involved in repressing mitochondrial respiration and the associated downstream functions [Chan et al., 2009; Favaro et al., 2010].”
BackgroundInterplay Between Reactive Oxygen Species and MicroRNAs in Cancer
He, J., & Jiang, B.-H. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0051-4 · Cited by 140
“In addition, inhibition of ISCU by miR-210 causes ROS induction in hypoxia, resulting in a shift to glycolysis in normoxia and enhanced cell survival [61].”
BackgroundmiR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia
Gou, D., Ramchandran, R., Peng, X., Yao, L., Kang, K., Sarkar, J., Wang, Z., Zhou, G., & Raj, J. U. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00344.2011 · Cited by 141
Bao, B., Ahmad, A., Kong, D., Ali, S. S., Azmi, A. S., Li, Y., Banerjee, S., Padhyé, S., & Sarkar, F. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043726 · Cited by 145
microRNAs: Innovative Targets for Cerebral Ischemia and Stroke
Ouyang, Y.-B., M. Stary, C., Yang, G.-Y., & Giffard, R. (2013) · Current Drug Targets · doi:10.2174/138945013804806424 · Cited by 137
“Many reports demonstrate that miR-210 overexpression causes mitochondrial dysfunction, with validated targets in complexes I – IV plus a Krebs cycle protein [126].”
BackgroundA critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease
Reddy, P. H., Tonk, S., Kumar, S., Vijayan, M., Kandimalla, R., Kuruva, C. S., & Reddy, A. P. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.067 · Cited by 143
miR-210 Targets Iron-Sulfur Cluster Scaffold Homologue in Human Trophoblast Cell Lines
Lee, D.-C., Romero, R., Kim, J.-S., Tarca, A. L., Montenegro, D., Pineles, B. L., Kim, E., Lee, J., Kim, S. Y., Draghici, S., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.035 · Cited by 135
miR-210: Fine-Tuning the Hypoxic Response
Ivan, M., & Huang, X. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-5915-6_10 · Cited by 135
“We observed hypoxic induction of ROS in cancer cell lines, and an miR-210 antagonist reversed this effect to almost normoxic levels (Favaro et al. 2010).”
BackgroundInfluentialSelf-citationCarbonell, T., & Gomes, A. V. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101607 · Cited by 143
Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment
Martínez‐Useros, J., Li, W., Cabeza-Morales, M., & García‐Foncillas, J. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6030029 · Cited by 135
“Several ROS-related miRNAs have been described and associated with cancer development [55].”
BackgroundThe tumour hypoxia induced non-coding transcriptome
Choudhry, H., Harris, A. L., & McIntyre, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.01.003 · Cited by 120
Self-citationGene Expression Signatures as Biomarkers of Tumour Hypoxia
Harris, B. H. L., Barberis, A., West, C., & Buffa, F. M. (2015) · Clinical Oncology · doi:10.1016/j.clon.2015.07.004 · Cited by 128
“The common hypoxia metagene was prognostic across three cancer types (breast lung and HNSCC) using four independent datasets comprising 295 breast, 216 lung and 80 HNSCC patients [56,98].”
MethodSelf-citationMicroRNAs in adipogenesis and as therapeutic targets for obesity
Alexander, R., Lodish, H. F., & Sun, L. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.561317 · Cited by 127
HypoxamiRs and Cancer: From Biology to Targeted Therapy
Gee, H. E., Ivan, C., Calin, G. A., & Ivan, M. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5639 · Cited by 116
“In addition to ISCU, which affects mitochondrial function indirectly, several integral components of the mitochondrial ETC have been found to be miR-210 targets: NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 4 (NDUFA4) and succinate dehydrogenase complex, subunit D (SDHD), in lung cancer cells, (136), and cytochr…”
BackgroundInfluentialSelf-citationPettersen, E. O., Ebbesen, P., Gieling, R. G., Williams, K. J., Dubois, L., Lambin, P., Ward, C., Meehan, J., Kunkler, I. H., Langdon, S. P., et al. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.966704 · Cited by 115
Self-citationHypoxia, angiogenesis, and metabolism in the hereditary kidney cancers
Chappell, J. C., Payne, L. B., & Rathmell, W. K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120855 · Cited by 115
Karshovska, E., Wei, Y., Subramanian, P., Mohibullah, R., Geißler, C., Baatsch, I. M., Popal, A., Corbalán-Campos, J., Exner, N., & Schober, A. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313290 · Cited by 127
Molecular Responses to Hypoxia-Inducible Factor 1α and Beyond
Brocato, J., Chervona, Y., & Costa, M. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.089623 · Cited by 128
Sousa Fialho, M. D. L., Abd Jamil, A. H., Stannard, G. A., & Heather, L. C. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.024 · Cited by 112
Muralimanoharan, S., Guo, C. C., Myatt, L., & Maloyan, A. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.45 · Cited by 122
EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination
Gómez-Maldonado, L., Tiana, M., Roche, O., Prado‐Cabrero, A., Jensen, L. D., Fernández‐Barral, A., Guijarro-Muñoz, I., Favaro, E., Moreno‐Bueno, G., Sanz, L., et al. (2014) · Oncogene · doi:10.1038/onc.2014.200 · Cited by 135
Self-citationThe clinical potential of microRNAs
Budhu, A., Ji, J., & Wang, X. W. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-37 · Cited by 109
“In addition, microRNAs play roles in regulating the expression of hypoxia-related genes, vascular endothelial growth factors [34-36].”
BackgroundThe emerging roles of microRNAs in cancer metabolism
Chan, B., Manley, J., Lee, J., & Singh, S. R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.011 · Cited by 109
Post-Transcriptional Control of the Hypoxic Response by RNA-Binding Proteins and MicroRNAs
Gorospe, M., Tominaga, K., Wu, X., Fähling, M., & Ivan, M. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00007 · Cited by 109
Self-citationSkeletal muscle energy metabolism in environmental hypoxia: climbing towards consensus
Horscroft, J. A., & Murray, A. J. (2014) · Extreme Physiology & Medicine · doi:10.1186/2046-7648-3-19 · Cited by 117
“an enzyme of the TCA cycle, are known to be particularly susceptible to HIF-mediated loss of function via miR-210 upregulation [50,51].”
BackgroundNakada, C., Tsukamoto, Y., Matsuura, K., Nguyen, T. L., Hijiya, N., Uchida, T., Sato, F., Mimata, H., Seto, M., & Moriyama, M. (2011) · The Journal of Pathology · doi:10.1002/path.2860 · Cited by 116
The cellular response to hypoxia: tuning the system with microRNAs
Loscalzo, J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci45105 · Cited by 105
Nie, Y., Han, B.-M., Liu, X.-B., Yang, J.-J., Wang, F., Cong, X.-F., & Chen, X. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.762 · Cited by 104
“The reason could be because miR-210 over-expression would create mitochondrial dysfunction by targeting the mitochondrial iron–sulfur scaffold protein ISCU [28] as well as members of electron transport chain (ETC) complex: NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 (NDUFA4) and succinate dehydrogenase compl…”
BackgroundHINCUTs in cancer: Hypoxia-induced noncoding ultraconserved transcripts
Ferdin, J., Nishida, N., Wu, X., Nicoloso, M. S., Shah, M. Y., Devlin, C., Ling, H., Shimizu, M., Kumar, K., Cortez, M. A., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.119 · Cited by 103
Self-citationMicroRNAs and their implications in toxicological research
Lema, C., & Cunningham, M. J. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.06.019 · Cited by 107
Hielscher, A., & Gerecht, S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.09.015 · Cited by 103
“miR-210 specifically targets the iron sulfur scaffolding protein ISCU, necessary for the proper assembly of iron complexes [38], which, in turn, regulate electron transport in the inner mitochondrial membrane [39].”
BackgroundMetabolic adaptation to chronic hypoxia in cardiac mitochondria
Heather, L. C., Cole, M. A., Tan, J. J., Ambrose, L. J. A., Pope, S. A. S., Jamil, A. H. A., Carter, E. E., Dodd, M. S., Yeoh, K. K., Schofield, C. J., et al. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0268-2 · Cited by 109
Regulation of Cancer Metabolism by Oncogenes and Tumor Suppressors
Iurlaro, R., León‐Annicchiarico, C. L., & Muñoz‐Pinedo, C. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00003-0 · Cited by 130
Iron–Sulfur Clusters: Biogenesis, Molecular Mechanisms, and Their Functional Significance
Xu, X. M., & Møller, S. G. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3259 · Cited by 128
“ISCU itself in eukaryotes is regulated by microRNA-210 (miR-210) (50, 51, 55, 83, 84) as miR-210 can directly target ISCU-like RNAs and suppress their expression.”
MicroRNA 210 as a Biomarker for Congestive Heart Failure
Endo, K., Naito, Y., Ji, X., Nakanishi, M., Noguchi, T., Goto, Y., Nonogi, H., Ma, X., Weng, H., Hirokawa, G., et al. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00578 · Cited by 115
Hypoxia-inducible Factor 1-α Induces miR-210 in Normoxic Differentiating Myoblasts
Cicchillitti, L., Stefano, V. D., Isaia, E., Crimaldi, L., Fasanaro, P., Ambrosino, V., Antonini, A., Capogrossi, M. C., Gaetano, C., Piaggio, G., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.421255 · Cited by 102
Toyama, T., Kondo, N., Endo, Y., Sugiura, H., Yoshimoto, N., Iwasa, M., Takahashi, S., Fujii, Y., & Yamashita, H. (2012) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hys001 · Cited by 96
“miR-210 overexpression in normoxia would create a mitochondrial dysfunction including a mismatch in electron transport that could lead to an increase in toxic reactive oxygen species (31) and increased apoptosis Figure 3.”
BackgroundInfluentialEmerging roles of miR-210 and other non-coding RNAs in the hypoxic response
Huang, X., & Zuo, J. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt141 · Cited by 97
MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease
Reddy, P. H., Williams, J. M., Smith, F., Bhatti, J. S., Kumar, S., Vijayan, M., Kandimalla, R. J. L., Kuruva, C. S., Wang, R., Mańczak, M., et al. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.009 · Cited by 102
Down the Iron Path: Mitochondrial Iron Homeostasis and Beyond
Dietz, J. V., Fox, J. L., & Khalimonchuk, O. (2021) · Cells · doi:10.3390/cells10092198 · Cited by 110
Gene expression and hypoxia in breast cancer
Favaro, E., Lord, S., Harris, A. L., & Buffa, F. M. (2011) · Genome Medicine · doi:10.1186/gm271 · Cited by 88
“Several targets have been investigated to date (Figure 2 and Table 4) showing roles for hsa-miR-210 in cell-cycle regulation, apoptosis, iron accumulation, the production of reactive oxygen species, cell metabolism, DNA repair, tumor initiation, and the survival, migration and differentiation of endothelial cells (Fig…”
InfluentialSelf-citationHypoxamiR Regulation and Function in Ischemic Cardiovascular Diseases
Greco, S., Gaetano, C., & Martelli, F. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5403 · Cited by 87
“According to its consistent induction in different hypoxic situations, miR-210 regulates several key aspects of cardiovascular disease, summarized in Figure 3 and Table 2 (17, 40, 44, 61, 109, 161).”
BackgroundMicroRNAs in tumor angiogenesis
Wang, W., Zhang, E., & Lin, C. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.06.025 · Cited by 91
“It was found that miR-210 increased the formation of ROS in MCF7 and HCT116 cell lines (Favaro et al. , 2010).”
BackgroundHypoxia and Mitochondrial Dysfunction in Pregnancy Complications
Hu, X., & Zhang, L. (2021) · Antioxidants · doi:10.3390/antiox10030405 · Cited by 109
“MiR-210-induced downregulation of ISCU disrupts the electron flow within Complex I and reduces its activity, leading to increased ROS production [191,192].”
BackgroundMicromanaging Iron Homeostasis
Yoshioka, Y., Kosaka, N., Ochiya, T., & Kato, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356717 · Cited by 86
“Although ISCU was known to be regulated by miR-210 in hypoxic condition (27, 28), the precise mechanism of miR-210 on iron homeostasis in cancer cells has not been clarified yet.”
BackgroundMethodHigh expression of miR-210 predicts poor survival in patients with breast cancer: A meta-analysis
Liu, H., Yang, J., Han, Y., Lu, Q., Cao, J., & Syed, L. H. (2012) · Gene · doi:10.1016/j.gene.2012.07.025 · Cited by 85
Cell-Autonomous Metabolic Reprogramming in Hypoxia
Schito, L., & Rey, S. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.10.006 · Cited by 89
Biggar, K. K., Kornfeld, S. F., Maistrovski, Y., & Storey, K. B. (2012) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2012.09.002 · Cited by 82
“In vertebrate studies miR-210 has been shown to repress mitochondrial respiration by targeting transcripts coding for iron-sulfur cluster assembly (ISCU1/2) proteins involved in electron transport function and mitochondrial reduction–oxidation reactions [23,24].”
BackgroundThe role of microRNAs in mitochondria in cancer
Vašků, J. B., Šáňa, J., & Slabý, O. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.001 · Cited by 89
Metadata
- Authors
- Favaro, E., Ramachandran, A., McCormick, R., Gee, H., Blancher, C., Crosby, M., Devlin, C., Blick, C., Buffa, F., Li, J.-L., Vojnovic, B., Pires das Neves, R., Glazer, P., Iborra, F., Ivan, M., Ragoussis, J., & Harris, A. L.
- Affiliations
- Centre for Human Genetics (GB)
- John Radcliffe Hospital (GB)
- Yale University (US)
- Indiana University Indianapolis (US)
- University of Oxford (GB)
- Corresponding author
- Ivan, Mircea
- Harris, Adrian L.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-04-26
- Volume
- 5
- Issue
- 4
- Pages
- e10345
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2859946
- OpenAlex
- W2044291869
- Cited by
- 324
- References
- 46
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 7 · 2023: 12 · 2022: 12 · 2021: 33 · 2020: 14 · 2019: 20 · 2018: 11 · 2017: 23 · 2016: 14 · 2015: 17 · 2014: 30 · 2013: 45 · 2012: 33
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, other-oa)
- PEARL (University of Plymouth) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Archivio istituzionale della Ricerca - Bocconi (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- Purdue University Indianapolis (Indiana University) (submittedVersion, cc-by)
- Publisher
- Funders
- Alliance for Cancer Gene Therapy
- Elsa U. Pardee Foundation
- Wellcome Trust
- Cancer Research UK
- National Institute for Health and Care Research
- University of Oxford
- European Commission
- Fondazione Italiana per la Ricerca sul Cancro
- Urology Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- miR-210, IscU, iron-sulfur cluster assembly, hypoxia, reactive oxygen species, TCA cycle, mitochondrial complex I, aconitase, HIF-1, tumor cell survival, prognosis, iron metabolism, microRNA target regulation
- MeSH terms
- Hypoxia, Citric Acid Cycle, Free Radicals, Humans, Iron-Sulfur Proteins, Mitochondria, Neoplasms, Prognosis, MicroRNAs, Electron Transport Complex I, Cell Line, Tumor, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.